India Allergy Diagnostics Market
Размер рынка в млрд долларов США
CAGR :
% 
USD
5.80 Billion
USD
13.26 Billion
2024
2032
 Прогнозируемый период |
2025 –2032 |
 Размер рынка (базовый год) |
USD 5.80 Billion |
 Размер рынка (прогнозируемый год) |
USD 13.26 Billion |
 CAGR |
% |
| Основные игроки рынка |
>India Allergy Diagnostics Market Segmentation, By Products and Services (Assay Kits, Instruments, Consumables and Services), Allergen (Inhaled Allergens, Food Allergens, Antibiotics, Other Drugs and Chemicals Allergens, Occupational Allergens, Miscellaneous Plant Allergens, Contact Allergens and Others), Test (In-Vitro Test and In-Vivo Test), End User (Hospitals, Diagnostic Laboratories, Academic Research Laboratories and Others), Distribution Channel (Direct and Indirect) – Industry Trends and Forecast to 2032
India Allergy Diagnostics Market Analysis
According to the WHO (World Health Organization), nearly 80% of the world's population lives in cities, and as a result, air quality has a substantial impact on them, mainly in low-income nations. In addition, multiple studies have linked air pollution to allergic rhinitis, asthma, and other disorders, leading to an increase in allergy diagnoses. Although allergies can affect practically every organ in the body and can be triggered by a variety of external causes, there are a few common themes that should be highlighted in research efforts. Effective prevention, curative therapy, and accurate, early diagnosis, as with many other chronic diseases, are key unmet requirements. In order to organise or re-categorize clinical symptoms into more coherent, consistent, and treatment-responsive groupings, detailed phenotyping/endotyping is widely required.
India Allergy Diagnostics Market Size
India allergy diagnostics market size was valued at USD 5.80 billion in 2024 and is projected to reach USD 13.26 billion by 2032, with a CAGR of 10.90% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes |
Allergy Diagnostics Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Thermo Fisher Scientific Inc., (US), Siemens Healthcare GmbH (Germany), Danaher (US), Omega Diagnostics Group PLC (UK), bioMérieux (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), NEOGEN Corporation (US), Eurofins Scientific (Luxembourg), Minaris Medical America, Inc. (US), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), and Erba Group (UK) |
|
Market Opportunities |
|
Allergy Diagnostics Market Definition
Allergies affect nearly every organ in the body in a variety of ways, with a wide range of symptoms, and hence their manifestations span a vast range of phenotypes. According to studies in Europe, up to 30% of the population suffers from allergic rhino conjunctivitis, 20% suffer from asthma, and 15% suffer from allergic skin diseases. Food allergies are growing more common and severe; occupational allergies, medication allergies, and insect sting allergies (which can be lethal) are all contributing to the allergy epidemic.
Allergy Diagnostics Market Dynamics
Drivers
- Increasing environmental pollution levels
Exposure to indoor and outdoor air pollution, allergies, and occupational exposure are the key risk factors for chronic respiratory illnesses. The prevalence of allergy diseases is higher in city dwellers than in rural people due to the higher exposure to environmental contaminants in cities (as a result of vehicular pollution and industrial activities). More than 80% of people living in cities are exposed to air quality levels that exceed WHO safety recommendations, according to the WHO, while this is a global trend, the implications are particularly severe in low-income countries' urban zones. This is a key indicator of the market's expansion in allergy diagnostics.
- Growing environmental pollution levels
The primary drivers of growth are rising healthcare expenditures and average lifespans, increased understanding of preventative testing, improved diagnostic test offerings, rising lifestyle-related diseases, and government-mandated healthcare treatments.
- Increase in the access to health insurance
The market is dominated by large hospitals and diagnostic laboratories, which can afford high-volume systems due to their large capital budgets. Rising healthcare expenditures aid the expansion of the allergy diagnostics market as a result of high healthcare service costs. In addition, governments in many countries are giving reimbursements and healthcare insurance programs to boost consumer demand for allergy diagnostics around the world.
Opportunities
- Use of m-Health technology in allergy diagnosis
Mobile Health tools for allergic rhinitis (AR) diagnosis published in peer-reviewed papers, the use of mHealth for rhinitis diagnosis is currently limited. A new breed of point-of-care devices has emerged as a result of recent advancements in integrated biosensors, wireless connectivity, and power harvesting techniques. AR, on the other hand, is a highly prevalent disease. Any diagnostic gadget connected to a smartphone (e.g., peak nasal inspiratory flow metres or intranasal biosensors) would have to be affordable.
Restraints/Challenges
- Difficulty in allergy diagnosis
The difficulty in allergy diagnosis is coming up with procedures that are objective, quick, repeatable, cost-effective, sensitive, and specific to the condition. They must be able to recognise exposures and contribute to therapeutic decision-making, preferably in primary care. In addition, tests to monitor therapy response and to compare preclinical and clinical effects across large cohorts and between nations are required.
- Premium costs associated with allergy diagnostic instruments
Market participants update several allergy diagnostic devices, including as luminometers, blot analyzers, scanners, ELISA analyzers, and immunoassay analyzers, on a regular basis. These instruments are more expensive since they have more advanced features and functions (the price of each instrument varies based on its accuracy, flexibility, and TAT). Immunoassay analyzers, for example, cost between USD 10,000 and USD 20,000, while luminometers cost between USD 3,000 and USD 14,000. ELISA readers that are semi-automated cost between USD 2,000 and USD 5,000, while fully automated analyzers cost over USD 14,000. In addition, operating this equipment necessitates extra costs such as maintenance and insurance, laboratory supervision, and overheads (such as utilities, space, and administration).
This India allergy diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the India allergy diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Allergy Diagnostics Market Scope
The India allergy diagnostics market is segmented on the basis of product, allergan, test, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Products
- Assay Kits
- Consumables
- Instruments
- Immunoassay Analyzers
- ELISA Analyzers
- Luminometers
- Other Instruments
- Services
Allergen
- Inhaled Allergens
- Food Allergens
- Drug Allergens
- Other Allergens
Test
- In Vivo Tests
- Skin Prick Tests
- Patch Tests
- Other In Vivo Tests
- In Vitro Tests
End User
- Diagnostic Laboratories
- Hospital-based Laboratories
- Academic Research Institutes
- Other End Users
Distribution Channel
- Direct
- Indirect
India Allergy Diagnostics Market Share
The India allergy diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to India allergy diagnostics market.
Some of the major players operating in the market are:
- Thermo Fisher Scientific Inc., (US)
- Siemens Healthcare GmbH (Germany)
- Danaher (US)
- Omega Diagnostics Group PLC (UK)
- bioMérieux (France)
- Romer Labs Division Holding (Austria)
- EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- HollisterStier Allergy (US)
- NEOGEN Corporation (US)
- Eurofins Scientific (Luxembourg)
- Minaris Medical America, Inc. (US)
- Stallergenes Greer (UK)
- HOB Biotech Group Corp., Ltd. (China)
- HYCOR Biomedical (US)
- R-Biopharm AG (Germany)
- AESKU.GROUP GmbH (Germany)
- ACON Laboratories, Inc. (US)
- Lincoln Diagnostics, Inc. (US)
- Astra Biotech GmbH (Germany)
- Erba Group (UK)
Latest Development in India Allergy Diagnostics Market
- In 2021, Hitachi Chemical Diagnostics, Inc. has been replaced by Minaris Medical America, Inc. By uniting the medical business group firms under the Minaris Medical brand, Hitachi wants to boost its global position and increase commercial activities in the field of in-vitro diagnostics. Showa Denko Materials Co., Ltd own both companies.
- In 2021, PerkinElmer Inc. has reached an agreement to purchase Immunodiagnostic Systems Holdings PLC. PerkinElmer Inc. will be able to strengthen its position in the ImmunoDiagnostics (IDS) industry as a result of the acquisition. EUROIMMUN Medizinische LABORDIAGNOSTIKA AG, a firm that sells allergy products and services, will take over IDS.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
